Plasma Gelsolin Promotes Proliferation of Mesangial Cell in IgA Nephropathy

Plasma Gelsolin Promotes Proliferation of Mesangial Cell in IgA Nephropathy

Background/Aims: Plasma gelsolin (pGSN) is an actin-binding protein that plays a critical role in the pathogenesis of rheumatoid arthritis. However, whether pGSN is involved in other immunological diseases remains unknown. This study focused on the relationship between pGSN and immunoglobulin A (IgA...

Full description

Bibliographic Details
Main Authors:	Lei Zhang, Dan Kong, Hongxue Meng, Changsong Han, Jiang Zhu, Juanjuan Qiao, Yan He, Tianzhen Wang, Xiaobo Li, Fengmin Zhang, Xiaoming Jin
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2016-12-01
Series:	Cellular Physiology and Biochemistry
Subjects:	IgA nephropathy (IgAN) Plasma gelsolin (pGSN) Human mesangial cells (HMCs) Transforming growth factor beta1 (TGF-β1) Progression and prognosis
Online Access:	http://www.karger.com/Article/FullText/453199

Similar Items

Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia
by: Julie V. Catteeuw, et al.
Published: (2021-11-01)

Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system
by: C Wang, et al.
Published: (2011-12-01)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
by: Pei Chen, et al.
Published: (2018-10-01)

The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistance
by: Hafiza Bushra Manzoor, et al.
Published: (2024-01-01)

IgA Enhances IGF-1 Mitogenic Activity Via Receptor Modulation in Glomerular Mesangial Cells: Implications for IgA-Induced Nephropathy
by: Amal Al-Eisa, et al.
Published: (2017-06-01)

Proliferation and Cytokine Production of Human Mesangial Cells Stimulated by Secretory IgA Isolated from Patients with IgA Nephropathy
by: Yan Liang, et al.
Published: (2015-07-01)

SUMO1 Promotes Mesangial Cell Proliferation Through Inhibiting Autophagy in a Cell Model of IgA Nephropathy
by: Xia Tan, et al.
Published: (2022-03-01)

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
by: Dana V. Rizk, et al.
Published: (2019-03-01)

Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
by: Toshimichi Onuma, et al.
Published: (2022-10-01)

Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway
by: Wencheng Xu, et al.
Published: (2023-06-01)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
by: Huixian Li, et al.
Published: (2021-12-01)

Prognostic role of mesangial IgM deposition in IgA nephropathy: a long-term cohort study
by: Gabriel Stefan, et al.
Published: (2024-12-01)

Hypertriglyceridemia Is Associated with More Severe Histological Glomerulosclerosis in IgA Nephropathy
by: Won Jung Choi, et al.
Published: (2021-09-01)

Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation
by: Mateus Justi Luvizotto, et al.
Published: (2022-11-01)

Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
by: Meshach Asare-Werehene, et al.
Published: (2022-02-01)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
by: Marios Papasotiriou, et al.
Published: (2022-02-01)

Recombinant human plasma gelsolin reverses increased permeability of the blood–brain barrier induced by the spike protein of the SARS-CoV-2 virus
by: Łukasz Suprewicz, et al.
Published: (2022-11-01)

Plasma gelsolin levels are associated with diabetes, sex, race, and poverty
by: Nicole Noren Hooten, et al.
Published: (2023-03-01)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
by: Yukako Ohyama, et al.
Published: (2021-08-01)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

Emerging Modes of Treatment of IgA Nephropathy
by: Dita Maixnerova, et al.
Published: (2020-11-01)

Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores
by: Dana V. Rizk, et al.
Published: (2023-11-01)

Orange-derived and dexamethasone-encapsulated extracellular vesicles reduced proteinuria and alleviated pathological lesions in IgA nephropathy by targeting intestinal lymphocytes
by: Wang Zhang, et al.
Published: (2022-08-01)

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
by: Youxia Liu, et al.
Published: (2022-01-01)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01)

Factors associated with the progression of mesangial lesions in IgA nephropathy: A comparative analysis of renal re-biopsies
by: Yetong Li, et al.
Published: (2022-11-01)

Association between geriatric nutritional risk index and pathological phenotypes of IgA nephropathy
by: Yangang Gan, et al.
Published: (2023-02-01)

Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy
by: Junjun Zhang, et al.
Published: (2021-04-01)

The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer
by: Meshach Asare-Werehene, et al.
Published: (2023-04-01)

Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation
by: Ming Xia, et al.
Published: (2022-06-01)

The Impact of Obesity on the Severity of Clinicopathologic Parameters in Patients with IgA Nephropathy
by: Yu Ah Hong, et al.
Published: (2020-08-01)

The Glomerulus According to the Mesangium
by: Kerstin Ebefors, et al.
Published: (2022-01-01)

The Role of Renal Macrophage, AIM, and TGF-β1 Expression in Renal Fibrosis Progression in IgAN Patients
by: Min Yang, et al.
Published: (2021-06-01)

The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy
by: Jingying Zhao, et al.
Published: (2021-04-01)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
by: Yusuke Fukao, et al.
Published: (2022-06-01)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2017-11-01)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
by: Yan-feng Zhao, et al.
Published: (2017-09-01)

Identification of GMFG as a novel biomarker in IgA nephropathy based on comprehensive bioinformatics analysis
by: Xiaoqi Deng, et al.
Published: (2024-04-01)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01)

Altered Expression Ratio of Actin-Binding Gelsolin Isoforms Is a Novel Hallmark of Mitochondrial OXPHOS Dysfunction
by: Alberto García-Bartolomé, et al.
Published: (2020-08-01)